Cargando…

Insulin-like growth factor-1 in myocardial tissue: interaction with tumor necrosis factor

Insulin-like growth factor (IGF)-1 is a well characterized growth factor that plays a role in the regulation of myocardial structure and function. Using an ex vivo murine model, Davani and coworkers, in this issue of Critical Care, demonstrate that IGF-1 confers cardiac protection against ischemia v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Meijing, Tsai, Ben, Brown, John W, Meldrum, Daniel R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC374379/ https://www.ncbi.nlm.nih.gov/pubmed/14624679

Ejemplares similares

The emerging role of insulin-like growth factor 1 receptor (IGF1r) in gastrointestinal stromal tumors (GISTs)
por: Pantaleo, Maria A, et al.
Publicado: (2010)

Follicular fluid has more to offer: Insulin-like growth factor axis on ovarian carcinogenesis
por: Chu, Tiffany, et al.
Publicado: (2019)

Tumor necrosis factor-α and muscle wasting: a cellular perspective
por: Reid, Michael B, et al.
Publicado: (2001)

In silico interaction of insulin-like growth factor binding protein 3 with insulin-like growth factor 1
por: Jafari, Elham, et al.
Publicado: (2018)

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice
por: Scheinberg, Morton, et al.
Publicado: (2014)

Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues
por: Ipsa, Emina, et al.
Publicado: (2019)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

Tumor Necrosis Factor Alpha and Insulin-Like Growth Factor 1 Induced Modifications of the Gene Expression Kinetics of Differentiating Skeletal Muscle Cells
por: Meyer, Swanhild U., et al.
Publicado: (2015)

Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
por: Rosenbloom, Arlan L.
Publicado: (2009)

Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development
Publicado: (1992)

SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2003)

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine
por: Felice, Carla, et al.
Publicado: (2019)

Elevated expression levels of serum insulin‐like growth factor‐1, tumor necrosis factor‐α and vascular endothelial growth factor 165 might exacerbate type 2 diabetic nephropathy
por: Li, Xiang, et al.
Publicado: (2016)

Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function
por: Marshman, Emma, et al.
Publicado: (2002)

The Role of Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins in the Nervous System
por: Lewitt, Moira S, et al.
Publicado: (2019)

Differential Expression of Insulin-Like Growth Factor-I Receptor on Human Bone Marrow-Derived Mesenchymal Stem Cells Induced by Tumor Necrosis Factor-α
por: Sahraean, Z., et al.
Publicado: (2014)

Insulin-like growth factor 1 myocardial expression decreases in chronic alcohol consumption
por: Borrisser-Pairó, Francesc, et al.
Publicado: (2013)

Interaction of AIM with insulin-like growth factor-binding protein-4
por: YOU, QIANG, et al.
Publicado: (2015)

The Insulin-Like Growth Factor System
por: Roith, Derek Le
Publicado: (2003)

Insulin-like growth factors and cancer.
por: Macaulay, V. M.
Publicado: (1992)

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
por: Van den Bosch, Filip, et al.
Publicado: (2005)

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines
Publicado: (1988)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction
por: Nederlof, Rianne, et al.
Publicado: (2022)

Role of the Interaction of Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors 1 and 2 in Bone-Related Cells
por: Kitaura, Hideki, et al.
Publicado: (2022)

Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients
por: Pouriamehr, Somayeh, et al.
Publicado: (2019)

The Insight into Insulin-Like Growth Factors and Insulin-Like Growth-Factor-Binding Proteins and Metabolic Profile in Pediatric Obesity
por: Czogała, Wojciech, et al.
Publicado: (2021)

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022)

Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth
por: Shigyo, Michiko, et al.
Publicado: (2015)

Targeting insulin-like growth factor pathways
por: Yee, D
Publicado: (2006)

Insulin-like growth factors: the unrecognised oncogenes.
por: Westley, B. R., et al.
Publicado: (1995)

Insulin-Like Growth Factor-1 and Neuroinflammation
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2017)

Insulin-Like Growth Factor Pathway and the Thyroid
por: Smith, Terry J.
Publicado: (2021)

Insulin-like growth factor-1 and insulin-like growth factor binding protein 3 and risk of postoperative cognitive dysfunction
por: Jiang, Jue, et al.
Publicado: (2015)

Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
por: Fabbi, Patrizia, et al.
Publicado: (2015)

Growth Factors in the Nucleolus?
por: Pederson, Thoru
Publicado: (1998)

Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
por: Janiak, Adam, et al.
Publicado: (2013)

Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta
Publicado: (1989)

Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma Progression
por: Murekatete, Berline, et al.
Publicado: (2018)

Tumor necrosis factor alpha modulates fibroblast-like synoviocyte expression of lymphangiogenesis-associated vascular endothelial growth factor C
por: Connor, AM, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_8dqtp9taqld1et6lg81ej9dev5